These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1020362)

  • 1. [Effectivity of intermittent treatment in patients with sputum-positive silico-tuberculosis (author's transl)].
    Frenzel I; Frenzel M; Cramer G; Niegsch G
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):153-60. PubMed ID: 1020362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
    Frenzel I; Neumeyer D
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
    Kameda K; Kawabata S; Masuda N
    Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of regimens containing INH, RFP with varied chemotherapy courses on retreated culture positive pneumoconio-tuberculosis].
    Jiang W; Chen H; Gao J; Huaibei M
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):648-50. PubMed ID: 11477888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late results of strictly supervised treatment of patients with newly detected pulmonary tuberculosis].
    Jozefovics F; Barbu Z; Bálinth E; Lubeniţă F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1980; 29(3):143-8. PubMed ID: 6254127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cooperative study on the recurrence of lung tuberculosis in East Germany].
    Fischer P; Cramer G; Götz J; Merkel S; Thomas E; Völker L
    Z Erkr Atmungsorgane; 1984; 163(2):191-7. PubMed ID: 6506806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone and joint tuberculosis concurrent with tuberculosis of other organs].
    Yagi O; Kawabe Y; Nagayama N; Shimada M; Kawashima M; Kaneko Y; Ariga H; Ohshima N; Matsui Y; Suzuki J; Masuda K; Tamura A; Nagai H; Akagawa S; Machida K; Kurashima A; Nakajima Y; Yotsumoto H
    Kekkaku; 2007 Jun; 82(6):523-9. PubMed ID: 17633120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis.
    Shiraishi Y; Nakajima Y; Katsuragi N; Kurai M; Takahashi N
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):523-8. PubMed ID: 15457152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
    Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
    Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
    Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
    Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.